Jens Gruber, Ph.D.

Jens studied „Molecular Biology“ at the International Max-Planck Research School in Göttingen and received his PhD with summa cum laude for studies on RNA interference at the Max-Planck Institute for Biophysical Chemistry in 2005. After postdoc positions in Germany (Max-Planck Society) and the Netherlands (AMC, University of Amsterdam) he led the research group “Medical RNA Biology” at the German Primate Center. During his career in academia, Jens received grants from multiple national and international organizations (DFG, BMBF, Leibniz Society, Max-Planck-Society, Life Science Foundation, Elsbeth-Bonhoff Foundation, Brazilian cNPQ and Colombian COLCIENCIAS), co-founded a biotech start-up (VD2Tec), was elected to the Young Leaders in Science Program (Schering Foundation), became a full GGNB (Göttingen Graduate School for Neurosciences and Molecular Biosciences) member and published numerous scientific papers and patents. In 2020, Jens co-founded the Curexsys GmbH and is now active as managing director and chief scientific officer.